Alternative names (3)
canBeTherapeuticFor • therapeutic use • therapeuticUseRandom triples
| Subject | Object |
|---|---|
| gptkb:CHEMBL1401 | gptkb:antiarrhythmic_agent |
| gptkb:CHEMBL1161 | gptkb:antiarrhythmic_agent |
| gptkb:CHEMBL691 | gptkb:antihypertensive_agent |
| gptkb:CHEMBL1431 | gptkb:antihypertensive_agent |
| gptkb:CHEMBL135 | gptkb:antihypertensive_agent |
| gptkb:CHEMBL1227 | gptkb:antiarrhythmic_agent |
| gptkb:beta-(Aminomethyl)-4-chlorobenzenepropanoic_acid | treatment of spasticity |
| gptkb:CHEMBL153 | antianginal agent |
| gptkb:Lucid_dream | Nightmare treatment |
| gptkb:IL-15 | gptkb:immunotherapy |
| gptkb:programmed_cell_death_protein_1 | autoimmune disease modulation |
| gptkb:CHEMBL1163 | antianginal agent |
| gptkb:SR141716A | gptkb:smoking_cessation_aid |
| gptkb:CYP2C19_inhibitors | alter drug plasma levels |
| gptkb:AMRAD_EPO | treatment of anemia |
| gptkb:MTX512 | treatment of type 2 diabetes |
| gptkb:H02AB_-_Glucocorticoids | anti-inflammatory |
| gptkb:NS16004 | anxiolysis |
| gptkb:CHEMBL153 | gptkb:antihypertensive_agent |
| gptkb:idebenone | treatment of Leber's hereditary optic neuropathy |